Literature DB >> 32641599

PD-L1 expression in regional lymph nodes and predictable roles in anti-cancer immune responses.

Yoshihiro Komohara1,2, Mamoru Harada3, Koji Ohnishi1, Keiichiro Kumamoto4, Toshiyuki Nakayama4.   

Abstract

Entities:  

Keywords:  CD169; PD-L1; dendritic cell; lymph node; macrophage

Mesh：

Substances：

Year:  2020        PMID： 32641599      PMCID： PMC7596915          DOI： 10.3960/jslrt.20015

Source DB:  PubMed          Journal:  J Clin Exp Hematop        ISSN： 1346-4280


× No keyword cloud information.
  26 in total

1.  High CD169 expression in lymph node macrophages predicts a favorable clinical course in patients with esophageal cancer.

Authors:  Hiroto Takeya; Takuya Shiota; Taisuke Yagi; Koji Ohnishi; Yoshifumi Baba; Yuko Miyasato; Yuki Kiyozumi; Naoya Yoshida; Motohiro Takeya; Hideo Baba; Yoshihiro Komohara
Journal:  Pathol Int       Date:  2018-12-05       Impact factor: 2.534

2.  Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL.

Authors:  Wei Ding; Betsy R LaPlant; Timothy G Call; Sameer A Parikh; Jose F Leis; Rong He; Tait D Shanafelt; Sutapa Sinha; Jennifer Le-Rademacher; Andrew L Feldman; Thomas M Habermann; Thomas E Witzig; Gregory A Wiseman; Yi Lin; Erik Asmus; Grzegorz S Nowakowski; Michael J Conte; Deborah A Bowen; Casey N Aitken; Daniel L Van Dyke; Patricia T Greipp; Xin Liu; Xiaosheng Wu; Henan Zhang; Charla R Secreto; Shulan Tian; Esteban Braggio; Linda E Wellik; Ivana Micallef; David S Viswanatha; Huihuang Yan; Asher A Chanan-Khan; Neil E Kay; Haidong Dong; Stephen M Ansell
Journal:  Blood       Date:  2017-04-19       Impact factor: 22.113

3.  Evaluation of PD-L1 biomarker for immune checkpoint inhibitor (PD-1/PD-L1 inhibitors) treatments for urothelial carcinoma patients: A meta-analysis.

Authors:  Xin Rui; Ting-Ting Gu; Hua-Feng Pan; Hui-Zhi Zhang
Journal:  Int Immunopharmacol       Date:  2018-12-22       Impact factor: 4.932

4.  Optimum immunohistochemical procedures for analysis of macrophages in human and mouse formalin fixed paraffin-embedded tissue samples.

Authors:  Takenobu Nakagawa; Koji Ohnishi; Yui Kosaki; Yoichi Saito; Hasita Horlad; Yukio Fujiwara; Motohiro Takeya; Yoshihiro Komohara
Journal:  J Clin Exp Hematop       Date:  2017

5.  Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity.

Authors:  Tyler J Curiel; Shuang Wei; Haidong Dong; Xavier Alvarez; Pui Cheng; Peter Mottram; Roman Krzysiek; Keith L Knutson; Ben Daniel; Maria Carla Zimmermann; Odile David; Matthew Burow; Alan Gordon; Nina Dhurandhar; Leann Myers; Ruth Berggren; Akseli Hemminki; Ronald D Alvarez; Dominique Emilie; David T Curiel; Lieping Chen; Weiping Zou
Journal:  Nat Med       Date:  2003-04-21       Impact factor: 53.440

Review 6.  PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations.

Authors:  Weiping Zou; Jedd D Wolchok; Lieping Chen
Journal:  Sci Transl Med       Date:  2016-03-02       Impact factor: 17.956

7.  Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer.

Authors:  Peter Schmid; Sylvia Adams; Hope S Rugo; Andreas Schneeweiss; Carlos H Barrios; Hiroji Iwata; Véronique Diéras; Roberto Hegg; Seock-Ah Im; Gail Shaw Wright; Volkmar Henschel; Luciana Molinero; Stephen Y Chui; Roel Funke; Amreen Husain; Eric P Winer; Sherene Loi; Leisha A Emens
Journal:  N Engl J Med       Date:  2018-10-20       Impact factor: 91.245

Review 8.  Possible functions of CD169-positive sinus macrophages in lymph nodes in anti-tumor immune responses.

Authors:  Yoshihiro Komohara; Koji Ohnishi; Motohiro Takeya
Journal:  Cancer Sci       Date:  2017-03-07       Impact factor: 6.716

9.  An IL-27/Stat3 axis induces expression of programmed cell death 1 ligands (PD-L1/2) on infiltrating macrophages in lymphoma.

Authors:  Hasita Horlad; Chaoya Ma; Hiromu Yano; Cheng Pan; Koji Ohnishi; Yukio Fujiwara; Shinya Endo; Yoshitaka Kikukawa; Yutaka Okuno; Masao Matsuoka; Motohiro Takeya; Yoshihiro Komohara
Journal:  Cancer Sci       Date:  2016-11       Impact factor: 6.716

10.  Reduced number of CD169+ macrophages in pre-metastatic regional lymph nodes is associated with subsequent metastatic disease in an animal model and with poor outcome in prostate cancer patients.

Authors:  Kerstin Strömvall; Kristoffer Sundkvist; Börje Ljungberg; Sofia Halin Bergström; Anders Bergh
Journal:  Prostate       Date:  2017-09-07       Impact factor: 4.104
View more
  1 in total

1.  CD169 Expression on Lymph Node Macrophages Predicts in Patients With Gastric Cancer.

Authors:  Keiichiro Kumamoto; Takashi Tasaki; Koji Ohnishi; Michihiko Shibata; Shohei Shimajiri; Masaru Harada; Yoshihiro Komohara; Toshiyuki Nakayama
Journal:  Front Oncol       Date:  2021-03-19       Impact factor: 6.244
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.